Toshiyuki Itai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Toshiyuki Itai has a total of 242 co-authors. Here are the top co-authors by number of shared publications:
- Naomichi Matsumoto
Department of Human Genetics Yokohama City University Graduate School of Medicine Yokohama Japan
8 shared publications Atsushi Fujita
Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
7 shared publicationsEriko Koshimizu
Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
6 shared publications- Naomi Tsuchida
Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
6 shared publications - Yuri Uchiyama
Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
6 shared publications - Satoko Miyatake
Department of Human Genetics Yokohama City University Graduate School of Medicine Yokohama Japan
5 shared publications
Latest Publications
- Open Access
- 9 July 2026
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (12) , 2601-2607
Cerebellar Abnormalities in the Neuroimaging Spectrum of CLTC ‐Related Disorder
Pathogenic variants in CLTC, which encodes the clathrin heavy chain involved in vesicle‐mediated trafficking in neurons, cause a rare neurodevelopmental disorder associated with variable severity of global developmental delay and intellectual disability and structural brain abnormalities. Although corpus callosum and white matter anomalies are commonly reported, the neuroimaging spectrum associated with CLTC variants has not been systematically reviewed. We report a patient with a novel de novo heterozygous missense CLTC variant presenting with brain MRI findings of pontine hypoplasia and cerebellar atrophy, abnormalities rarely described in association with this condition. Moreover, we conducted a comprehensive review of the literature, including re‐evaluation of available neuroimaging, to summarize cerebral imaging findings in 30 individuals, including our case. Pontine hypoplasia and cerebellar atrophy expand the known neuroimaging phenotype of CLTC ‐related disorder. In addition, our review supports a potential genotype–phenotype correlation, suggesting that missense variants may be associated with a more severe phenotype.
- 9 July 2026
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (12) , 2601-2607
Open AccessCerebellar Abnormalities in the Neuroimaging Spectrum of CLTC ‐Related Disorder
Pathogenic variants in CLTC, which encodes the clathrin heavy chain involved in vesicle‐mediated trafficking in neurons, cause a rare neurodevelopmental disorder associated with variable severity of global developmental delay and intellectual disability and structural brain abnormalities. Although corpus callosum and white matter anomalies are commonly reported, the neuroimaging spectrum associated with CLTC variants has not been systematically reviewed. We report a patient with a novel de novo heterozygous missense CLTC variant presenting with brain MRI findings of pontine hypoplasia and cerebellar atrophy, abnormalities rarely described in association with this condition. Moreover, we conducted a comprehensive review of the literature, including re‐evaluation of available neuroimaging, to summarize cerebral imaging findings in 30 individuals, including our case. Pontine hypoplasia and cerebellar atrophy expand the known neuroimaging phenotype of CLTC ‐related disorder. In addition, our review supports a potential genotype–phenotype correlation, suggesting that missense variants may be associated with a more severe phenotype.
- 5 February 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (2) , e70193
Cervical Cerclage at 17 Gestational Weeks for Delayed‐Interval Delivery at 15 and 27 Weeks of Gestation in a Dichorionic Twin Pregnancy: A Case Report
Delayed‐interval delivery refers to the delivery of the remaining fetus(es) at least 24 h after the delivery of the first fetus. There have been limited case reports of delayed‐interval deliveries in twin pregnancies whose delivery of the first twin occurred in the early second trimester. We report a delayed‐interval delivery of a dichorionic diamniotic pregnancy complicated by multiple fibroids. A 38‐year‐old primipara woman delivered the first twin at 15 weeks and 3 days of gestation. She did not have uterine contractions or any signs of infection, then McDonald cerclage was performed at 17 weeks and 1 day of gestation. At 27 weeks and 2 days of gestation, the second twin, 922 g, was delivered by caesarean section after premature rupture of membranes. Delayed‐interval delivery may be considered in the early second trimester if there is no evidence of uterine contractions or infection, even in patients at risk for preterm birth.
- 5 February 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (2) , e70193
Cervical Cerclage at 17 Gestational Weeks for Delayed‐Interval Delivery at 15 and 27 Weeks of Gestation in a Dichorionic Twin Pregnancy: A Case Report
Delayed‐interval delivery refers to the delivery of the remaining fetus(es) at least 24 h after the delivery of the first fetus. There have been limited case reports of delayed‐interval deliveries in twin pregnancies whose delivery of the first twin occurred in the early second trimester. We report a delayed‐interval delivery of a dichorionic diamniotic pregnancy complicated by multiple fibroids. A 38‐year‐old primipara woman delivered the first twin at 15 weeks and 3 days of gestation. She did not have uterine contractions or any signs of infection, then McDonald cerclage was performed at 17 weeks and 1 day of gestation. At 27 weeks and 2 days of gestation, the second twin, 922 g, was delivered by caesarean section after premature rupture of membranes. Delayed‐interval delivery may be considered in the early second trimester if there is no evidence of uterine contractions or infection, even in patients at risk for preterm birth.
- Open Access
- 1 January 2025
- Published by Wiley in Congenital Anomalies
- Vol. 65 (1) , e70013
Radiation‐induced congenital malformations in Fukushima after the Fukushima Daiichi Nuclear Disaster
The Fukushima Daiichi Nuclear Disaster (FDND) occurred in 2011, which occurred after the Great East Japan Earthquake. However, how the incidence of radiation‐induced malformations in Fukushima has been affected by FDND remains to be elucidated. To address this, we analyzed birth data from Fukushima and other areas in Japan from the International Clearinghouse for Birth Defects Surveillance and Research Japan Center, including information on birth defects between January 2010 and December 2022. Among the registered birth defects, microcephaly, microphthalmia, and neural tube defects were classified as radiation‐induced malformations. Our study included 90 433 births in Fukushima, accounting for 52.6% of all births. Among these, birth defects were observed in 1376 (1.52%) births, of which 28 (0.031%) were diagnosed with radiation‐induced malformations. With regard to other areas in Japan, 1 323 391 births, which accounted for 10.9% of all births, were registered; births with birth defects and radiation‐induced malformations were observed in 37 490 (3.67%) and 889 (0.067%), respectively. Because sampling bias was suspected, we compared the rates of radiation‐induced malformations in Fukushima and other areas in Japan by adjusting the incidence in Fukushima with the incidences of ventricular septal defects in both areas. However, there was no statistically significant difference between them. Our results, which covered the largest number of births in Fukushima, did not find a significant increase in the incidence of radiation‐induced malformations in Fukushima since FDND.
- 1 January 2025
- Published by Wiley in Congenital Anomalies
- Vol. 65 (1) , e70013
Open AccessRadiation‐induced congenital malformations in Fukushima after the Fukushima Daiichi Nuclear Disaster
The Fukushima Daiichi Nuclear Disaster (FDND) occurred in 2011, which occurred after the Great East Japan Earthquake. However, how the incidence of radiation‐induced malformations in Fukushima has been affected by FDND remains to be elucidated. To address this, we analyzed birth data from Fukushima and other areas in Japan from the International Clearinghouse for Birth Defects Surveillance and Research Japan Center, including information on birth defects between January 2010 and December 2022. Among the registered birth defects, microcephaly, microphthalmia, and neural tube defects were classified as radiation‐induced malformations. Our study included 90 433 births in Fukushima, accounting for 52.6% of all births. Among these, birth defects were observed in 1376 (1.52%) births, of which 28 (0.031%) were diagnosed with radiation‐induced malformations. With regard to other areas in Japan, 1 323 391 births, which accounted for 10.9% of all births, were registered; births with birth defects and radiation‐induced malformations were observed in 37 490 (3.67%) and 889 (0.067%), respectively. Because sampling bias was suspected, we compared the rates of radiation‐induced malformations in Fukushima and other areas in Japan by adjusting the incidence in Fukushima with the incidences of ventricular septal defects in both areas. However, there was no statistically significant difference between them. Our results, which covered the largest number of births in Fukushima, did not find a significant increase in the incidence of radiation‐induced malformations in Fukushima since FDND.
- Open Access
- 27 May 2024
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 5 (3) , 100313
Investigating gene functions and single-cell expression profiles of de novo variants in orofacial clefts
- 27 May 2024
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 5 (3) , 100313
Open AccessInvestigating gene functions and single-cell expression profiles of de novo variants in orofacial clefts
- Open Access
- 9 March 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1
Publisher Correction: A novel NONO variant that causes developmental delay and cardiac phenotypes
- 9 March 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1
Open AccessPublisher Correction: A novel NONO variant that causes developmental delay and cardiac phenotypes
- 2 March 2023
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 192 (3-4) , 62-70
De novo mutations disturb early brain development more frequently than common variants in schizophrenia
Investigating functional, temporal, and cell‐type expression features of mutations is important for understanding a complex disease. Here, we collected and analyzed common variants and de novo mutations (DNMs) in schizophrenia (SCZ). We collected 2,636 missense and loss‐of‐function (LoF) DNMs in 2,263 genes across 3,477 SCZ patients (SCZ‐DNMs). We curated three gene lists: (a) SCZ‐neuroGenes (159 genes), which are intolerant to LoF and missense DNMs and are neurologically important, (b) SCZ‐moduleGenes (52 genes), which were derived from network analyses of SCZ‐DNMs, and (c) SCZ‐commonGenes (120 genes) from a recent GWAS as reference. To compare temporal gene expression, we used the BrainSpan dataset. We defined a fetal effect score (FES) to quantify the involvement of each gene in prenatal brain development. We further employed the specificity indexes (SIs) to evaluate cell‐type expression specificity from single‐cell expression data in cerebral cortices of humans and mice. Compared with SCZ‐commonGenes, SCZ‐neuroGenes and SCZ‐moduleGenes were highly expressed in the prenatal stage, had higher FESs, and had higher SIs in fetal replicating cells and undifferentiated cell types. Our results suggested that gene expression patterns in specific cell types in early fetal stages might have impacts on the risk of SCZ during adulthood.
- 2 March 2023
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 192 (3-4) , 62-70
De novo mutations disturb early brain development more frequently than common variants in schizophrenia
Investigating functional, temporal, and cell‐type expression features of mutations is important for understanding a complex disease. Here, we collected and analyzed common variants and de novo mutations (DNMs) in schizophrenia (SCZ). We collected 2,636 missense and loss‐of‐function (LoF) DNMs in 2,263 genes across 3,477 SCZ patients (SCZ‐DNMs). We curated three gene lists: (a) SCZ‐neuroGenes (159 genes), which are intolerant to LoF and missense DNMs and are neurologically important, (b) SCZ‐moduleGenes (52 genes), which were derived from network analyses of SCZ‐DNMs, and (c) SCZ‐commonGenes (120 genes) from a recent GWAS as reference. To compare temporal gene expression, we used the BrainSpan dataset. We defined a fetal effect score (FES) to quantify the involvement of each gene in prenatal brain development. We further employed the specificity indexes (SIs) to evaluate cell‐type expression specificity from single‐cell expression data in cerebral cortices of humans and mice. Compared with SCZ‐commonGenes, SCZ‐neuroGenes and SCZ‐moduleGenes were highly expressed in the prenatal stage, had higher FESs, and had higher SIs in fetal replicating cells and undifferentiated cell types. Our results suggested that gene expression patterns in specific cell types in early fetal stages might have impacts on the risk of SCZ during adulthood.
- Open Access
- 18 January 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
A novel NONO variant that causes developmental delay and cardiac phenotypes
The Drosophila behavior/human splicing protein family is involved in numerous steps of gene regulation. In humans, this family consists of three proteins: SFPQ, PSPC1, and NONO. Hemizygous loss-of-function (LoF) variants in NONO cause a developmental delay with several complications (e.g., distinctive facial features, cardiac symptoms, and skeletal symptoms) in an X-linked recessive manner. Most of the reported variants have been LoF variants, and two missense variants have been reported as likely deleterious but with no functional validation. We report three individuals from two families harboring an identical missense variant that is located in the nuclear localization signal, NONO: NM_001145408.2:c.1375C > G p.(Pro459Ala). All of them were male and the variant was inherited from their asymptomatic mothers. Individual 1 was diagnosed with developmental delay and cardiac phenotypes (ventricular tachycardia and dilated cardiomyopathy), which overlapped with the features of reported individuals having NONO LoF variants. Individuals 2 and 3 were monozygotic twins. Unlike in Individual 1, developmental delay with autistic features was the only symptom found in them. A fly experiment and cell localization experiment showed that the NONO variant impaired its proper intranuclear localization, leading to mild LoF. Our findings suggest that deleterious NONO missense variants should be taken into consideration when whole-exome sequencing is performed on male individuals with developmental delay with or without cardiac symptoms.
- 18 January 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Open AccessA novel NONO variant that causes developmental delay and cardiac phenotypes
The Drosophila behavior/human splicing protein family is involved in numerous steps of gene regulation. In humans, this family consists of three proteins: SFPQ, PSPC1, and NONO. Hemizygous loss-of-function (LoF) variants in NONO cause a developmental delay with several complications (e.g., distinctive facial features, cardiac symptoms, and skeletal symptoms) in an X-linked recessive manner. Most of the reported variants have been LoF variants, and two missense variants have been reported as likely deleterious but with no functional validation. We report three individuals from two families harboring an identical missense variant that is located in the nuclear localization signal, NONO: NM_001145408.2:c.1375C > G p.(Pro459Ala). All of them were male and the variant was inherited from their asymptomatic mothers. Individual 1 was diagnosed with developmental delay and cardiac phenotypes (ventricular tachycardia and dilated cardiomyopathy), which overlapped with the features of reported individuals having NONO LoF variants. Individuals 2 and 3 were monozygotic twins. Unlike in Individual 1, developmental delay with autistic features was the only symptom found in them. A fly experiment and cell localization experiment showed that the NONO variant impaired its proper intranuclear localization, leading to mild LoF. Our findings suggest that deleterious NONO missense variants should be taken into consideration when whole-exome sequencing is performed on male individuals with developmental delay with or without cardiac symptoms.
- 5 April 2022
- Published by Wiley in Clinical Genetics
- Vol. 102 (1) , 3-11
De novo heterozygous variants in KIF5B cause kyphomelic dysplasia
Kyphomelic dysplasia is a heterogeneous group of skeletal dysplasias characterized by severe bowing of the limbs associated with other variable findings, such as narrow thorax and abnormal facies. We searched for the genetic etiology of this disorder. Four individuals diagnosed with kyphomelic dysplasia were enrolled. We performed whole‐exome sequencing and evaluated the pathogenicity of the identified variants. All individuals had de novo heterozygous variants in KIF5B encoding kinesin‐1 heavy chain: two with c.272A>G:p.(Lys91Arg), one with c.584C>A:p.(Thr195Lys), and the other with c.701G>T:p.(Gly234Val). All variants involved conserved amino acids in or close to the ATPase activity‐related motifs in the catalytic motor domain of the KIF5B protein. All individuals had sharp angulation of the femora and humeri, distinctive facial features, and neonatal respiratory distress. Short stature was observed in three individuals. Three developed postnatal osteoporosis with subsequent fractures, two showed brachycephaly, and two were diagnosed with optic atrophy. Our findings suggest that heterozygous KIF5B deleterious variants cause a specific form of kyphomelic dysplasia. Furthermore, alterations in kinesins cause various symptoms known as kinesinopathies, and our findings also extend the phenotypic spectrum of kinesinopathies.
- 5 April 2022
- Published by Wiley in Clinical Genetics
- Vol. 102 (1) , 3-11
De novo heterozygous variants in KIF5B cause kyphomelic dysplasia
Kyphomelic dysplasia is a heterogeneous group of skeletal dysplasias characterized by severe bowing of the limbs associated with other variable findings, such as narrow thorax and abnormal facies. We searched for the genetic etiology of this disorder. Four individuals diagnosed with kyphomelic dysplasia were enrolled. We performed whole‐exome sequencing and evaluated the pathogenicity of the identified variants. All individuals had de novo heterozygous variants in KIF5B encoding kinesin‐1 heavy chain: two with c.272A>G:p.(Lys91Arg), one with c.584C>A:p.(Thr195Lys), and the other with c.701G>T:p.(Gly234Val). All variants involved conserved amino acids in or close to the ATPase activity‐related motifs in the catalytic motor domain of the KIF5B protein. All individuals had sharp angulation of the femora and humeri, distinctive facial features, and neonatal respiratory distress. Short stature was observed in three individuals. Three developed postnatal osteoporosis with subsequent fractures, two showed brachycephaly, and two were diagnosed with optic atrophy. Our findings suggest that heterozygous KIF5B deleterious variants cause a specific form of kyphomelic dysplasia. Furthermore, alterations in kinesins cause various symptoms known as kinesinopathies, and our findings also extend the phenotypic spectrum of kinesinopathies.
- 7 July 2021
- Published by Springer Nature in Journal of Human Genetics
- Vol. 67 (1) , 1-7
Novel CLTC variants cause new brain and kidney phenotypes
Heterozygous variants in CLTC, which encode the clathrin heavy chain protein, cause neurodevelopmental delay of varying severity, and often accompanied by dysmorphic features, seizures, hypotonia, and ataxia. To date, 28 affected individuals with CLTC variants have been reported, although their phenotypes have not been fully elucidated. Here, we report three novel de novo CLTC (NM_001288653.1) variants in three individuals with previously unreported clinical symptoms: c.3662_3664del:p.(Leu1221del) in individual 1, c.2878T>C:p.(Trp960Arg) in individual 2, and c.2430+1G>T:p.(Glu769_Lys810del) in individual 3. Consistent with previous reports, individuals with missense or small in-frame variants were more severely affected. Unreported symptoms included a brain defect (cystic lesions along the lateral ventricles of the brain in individuals 1 and 3), kidney findings (high-echogenic kidneys in individual 1 and agenesis of the left kidney and right vesicoureteral reflux in individual 3), respiratory abnormality (recurrent pneumonia in individual 1), and abnormal hematological findings (anemia in individual 1 and pancytopenia in individual 3). Of note, individual 1 even exhibited prenatal abnormality (fetal growth restriction, cystic brain lesions, high-echogenic kidneys, and a heart defect), suggesting that CLTC variants should be considered when abnormal prenatal findings in multiple organs are detected.
- 7 July 2021
- Published by Springer Nature in Journal of Human Genetics
- Vol. 67 (1) , 1-7
Novel CLTC variants cause new brain and kidney phenotypes
Heterozygous variants in CLTC, which encode the clathrin heavy chain protein, cause neurodevelopmental delay of varying severity, and often accompanied by dysmorphic features, seizures, hypotonia, and ataxia. To date, 28 affected individuals with CLTC variants have been reported, although their phenotypes have not been fully elucidated. Here, we report three novel de novo CLTC (NM_001288653.1) variants in three individuals with previously unreported clinical symptoms: c.3662_3664del:p.(Leu1221del) in individual 1, c.2878T>C:p.(Trp960Arg) in individual 2, and c.2430+1G>T:p.(Glu769_Lys810del) in individual 3. Consistent with previous reports, individuals with missense or small in-frame variants were more severely affected. Unreported symptoms included a brain defect (cystic lesions along the lateral ventricles of the brain in individuals 1 and 3), kidney findings (high-echogenic kidneys in individual 1 and agenesis of the left kidney and right vesicoureteral reflux in individual 3), respiratory abnormality (recurrent pneumonia in individual 1), and abnormal hematological findings (anemia in individual 1 and pancytopenia in individual 3). Of note, individual 1 even exhibited prenatal abnormality (fetal growth restriction, cystic brain lesions, high-echogenic kidneys, and a heart defect), suggesting that CLTC variants should be considered when abnormal prenatal findings in multiple organs are detected.